Case Western Reserve researcher discovers new 'anti-pathogenic' drugs to treat MRSA
'Anti-pathogenic' drugs block MRSA's production of toxins thus rendering the bacteria harmless, treating the infection and potentially eliminating concern for resistance
20-Sep-2010 -
Menachem Shoham, PhD, associate professor and researcher in the department of biochemistry at the Case Western Reserve University School of Medicine, has identified new anti-pathogenic drugs that, without killing the bacteria, render Methicillin Resistant Staphylococcus Aureus (MRSA) harmless by ...
antibiotics
bacteria
biochemistry
+3